The impact of poor metabolic health on aggressive breast cancer: adipose tissue and tumor metabolism

Obesity and type 2 diabetes are chronic metabolic diseases that impact tens to hundreds of millions of adults, especially in developed countries. Each condition is associated with an elevated risk of breast cancer and with a poor prognosis after treatment. The mechanisms connecting poor metabolic he...

Full description

Bibliographic Details
Main Authors: Barbara Mensah Sankofi, Estefania Valencia-Rincón, Malika Sekhri, Adriana L. Ponton-Almodovar, Jamie J. Bernard, Elizabeth A. Wellberg
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1217875/full
_version_ 1797679239300907008
author Barbara Mensah Sankofi
Estefania Valencia-Rincón
Malika Sekhri
Adriana L. Ponton-Almodovar
Adriana L. Ponton-Almodovar
Adriana L. Ponton-Almodovar
Jamie J. Bernard
Jamie J. Bernard
Jamie J. Bernard
Elizabeth A. Wellberg
author_facet Barbara Mensah Sankofi
Estefania Valencia-Rincón
Malika Sekhri
Adriana L. Ponton-Almodovar
Adriana L. Ponton-Almodovar
Adriana L. Ponton-Almodovar
Jamie J. Bernard
Jamie J. Bernard
Jamie J. Bernard
Elizabeth A. Wellberg
author_sort Barbara Mensah Sankofi
collection DOAJ
description Obesity and type 2 diabetes are chronic metabolic diseases that impact tens to hundreds of millions of adults, especially in developed countries. Each condition is associated with an elevated risk of breast cancer and with a poor prognosis after treatment. The mechanisms connecting poor metabolic health to breast cancer are numerous and include hyperinsulinemia, inflammation, excess nutrient availability, and adipose tissue dysfunction. Here, we focus on adipose tissue, highlighting important roles for both adipocytes and fibroblasts in breast cancer progression. One potentially important mediator of adipose tissue effects on breast cancer is the fibroblast growth factor receptor (FGFR) signaling network. Among the many roles of FGFR signaling, we postulate that key mechanisms driving aggressive breast cancer include epithelial-to-mesenchymal transition and cellular metabolic reprogramming. We also pose existing questions that may help better understand breast cancer biology in people with obesity, type 2 diabetes, and poor metabolic health.
first_indexed 2024-03-11T23:11:37Z
format Article
id doaj.art-88e1b3d381f34e7baedfd133c9779c81
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-03-11T23:11:37Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-88e1b3d381f34e7baedfd133c9779c812023-09-21T08:32:56ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922023-09-011410.3389/fendo.2023.12178751217875The impact of poor metabolic health on aggressive breast cancer: adipose tissue and tumor metabolismBarbara Mensah Sankofi0Estefania Valencia-Rincón1Malika Sekhri2Adriana L. Ponton-Almodovar3Adriana L. Ponton-Almodovar4Adriana L. Ponton-Almodovar5Jamie J. Bernard6Jamie J. Bernard7Jamie J. Bernard8Elizabeth A. Wellberg9Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United StatesDepartment of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United StatesDepartment of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United StatesDepartment of Pharmacology and Toxicology, Michigan State University, East Lansing, MI, United StatesNicolas V. Perricone Division of Dermatology, Michigan State University, East Lansing, MI, United StatesDepartment of Medicine, Michigan State University, East Lansing, MI, United StatesDepartment of Pharmacology and Toxicology, Michigan State University, East Lansing, MI, United StatesNicolas V. Perricone Division of Dermatology, Michigan State University, East Lansing, MI, United StatesDepartment of Medicine, Michigan State University, East Lansing, MI, United StatesDepartment of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United StatesObesity and type 2 diabetes are chronic metabolic diseases that impact tens to hundreds of millions of adults, especially in developed countries. Each condition is associated with an elevated risk of breast cancer and with a poor prognosis after treatment. The mechanisms connecting poor metabolic health to breast cancer are numerous and include hyperinsulinemia, inflammation, excess nutrient availability, and adipose tissue dysfunction. Here, we focus on adipose tissue, highlighting important roles for both adipocytes and fibroblasts in breast cancer progression. One potentially important mediator of adipose tissue effects on breast cancer is the fibroblast growth factor receptor (FGFR) signaling network. Among the many roles of FGFR signaling, we postulate that key mechanisms driving aggressive breast cancer include epithelial-to-mesenchymal transition and cellular metabolic reprogramming. We also pose existing questions that may help better understand breast cancer biology in people with obesity, type 2 diabetes, and poor metabolic health.https://www.frontiersin.org/articles/10.3389/fendo.2023.1217875/fullbreast canceradiposefibroblast growth factorobesitydiabetes
spellingShingle Barbara Mensah Sankofi
Estefania Valencia-Rincón
Malika Sekhri
Adriana L. Ponton-Almodovar
Adriana L. Ponton-Almodovar
Adriana L. Ponton-Almodovar
Jamie J. Bernard
Jamie J. Bernard
Jamie J. Bernard
Elizabeth A. Wellberg
The impact of poor metabolic health on aggressive breast cancer: adipose tissue and tumor metabolism
Frontiers in Endocrinology
breast cancer
adipose
fibroblast growth factor
obesity
diabetes
title The impact of poor metabolic health on aggressive breast cancer: adipose tissue and tumor metabolism
title_full The impact of poor metabolic health on aggressive breast cancer: adipose tissue and tumor metabolism
title_fullStr The impact of poor metabolic health on aggressive breast cancer: adipose tissue and tumor metabolism
title_full_unstemmed The impact of poor metabolic health on aggressive breast cancer: adipose tissue and tumor metabolism
title_short The impact of poor metabolic health on aggressive breast cancer: adipose tissue and tumor metabolism
title_sort impact of poor metabolic health on aggressive breast cancer adipose tissue and tumor metabolism
topic breast cancer
adipose
fibroblast growth factor
obesity
diabetes
url https://www.frontiersin.org/articles/10.3389/fendo.2023.1217875/full
work_keys_str_mv AT barbaramensahsankofi theimpactofpoormetabolichealthonaggressivebreastcanceradiposetissueandtumormetabolism
AT estefaniavalenciarincon theimpactofpoormetabolichealthonaggressivebreastcanceradiposetissueandtumormetabolism
AT malikasekhri theimpactofpoormetabolichealthonaggressivebreastcanceradiposetissueandtumormetabolism
AT adrianalpontonalmodovar theimpactofpoormetabolichealthonaggressivebreastcanceradiposetissueandtumormetabolism
AT adrianalpontonalmodovar theimpactofpoormetabolichealthonaggressivebreastcanceradiposetissueandtumormetabolism
AT adrianalpontonalmodovar theimpactofpoormetabolichealthonaggressivebreastcanceradiposetissueandtumormetabolism
AT jamiejbernard theimpactofpoormetabolichealthonaggressivebreastcanceradiposetissueandtumormetabolism
AT jamiejbernard theimpactofpoormetabolichealthonaggressivebreastcanceradiposetissueandtumormetabolism
AT jamiejbernard theimpactofpoormetabolichealthonaggressivebreastcanceradiposetissueandtumormetabolism
AT elizabethawellberg theimpactofpoormetabolichealthonaggressivebreastcanceradiposetissueandtumormetabolism
AT barbaramensahsankofi impactofpoormetabolichealthonaggressivebreastcanceradiposetissueandtumormetabolism
AT estefaniavalenciarincon impactofpoormetabolichealthonaggressivebreastcanceradiposetissueandtumormetabolism
AT malikasekhri impactofpoormetabolichealthonaggressivebreastcanceradiposetissueandtumormetabolism
AT adrianalpontonalmodovar impactofpoormetabolichealthonaggressivebreastcanceradiposetissueandtumormetabolism
AT adrianalpontonalmodovar impactofpoormetabolichealthonaggressivebreastcanceradiposetissueandtumormetabolism
AT adrianalpontonalmodovar impactofpoormetabolichealthonaggressivebreastcanceradiposetissueandtumormetabolism
AT jamiejbernard impactofpoormetabolichealthonaggressivebreastcanceradiposetissueandtumormetabolism
AT jamiejbernard impactofpoormetabolichealthonaggressivebreastcanceradiposetissueandtumormetabolism
AT jamiejbernard impactofpoormetabolichealthonaggressivebreastcanceradiposetissueandtumormetabolism
AT elizabethawellberg impactofpoormetabolichealthonaggressivebreastcanceradiposetissueandtumormetabolism